|
GB0011903D0
(en)
*
|
2000-05-18 |
2000-07-05 |
Astrazeneca Ab |
Combination chemotherapy
|
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
CA2648099C
(en)
*
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
|
US9381477B2
(en)
*
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
US20100144845A1
(en)
*
|
2006-08-04 |
2010-06-10 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
EP2057987B1
(en)
*
|
2006-08-30 |
2015-03-04 |
Kyushu University, National University Corporation |
Pharmaceutical composition containing statin-encapsulated nanoparticle
|
|
US8168662B1
(en)
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8178564B2
(en)
*
|
2006-11-06 |
2012-05-15 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8168661B2
(en)
*
|
2006-11-06 |
2012-05-01 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US8173686B2
(en)
|
2006-11-06 |
2012-05-08 |
Poniard Pharmaceuticals, Inc. |
Use of picoplatin to treat colorectal cancer
|
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
US20110033528A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Poniard Pharmaceuticals, Inc. |
Stabilized picoplatin oral dosage form
|
|
EP2134830A2
(en)
|
2007-02-09 |
2009-12-23 |
Massachusetts Institute of Technology |
Oscillating cell culture bioreactor
|
|
WO2008124632A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
|
CA2926573C
(en)
*
|
2007-06-26 |
2018-08-28 |
The Johns Hopkins University |
Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents
|
|
US20100260832A1
(en)
*
|
2007-06-27 |
2010-10-14 |
Poniard Pharmaceuticals, Inc. |
Combination therapy for ovarian cancer
|
|
TW200916094A
(en)
*
|
2007-06-27 |
2009-04-16 |
Poniard Pharmaceuticals Inc |
Stabilized picoplatin dosage form
|
|
WO2009011861A1
(en)
*
|
2007-07-16 |
2009-01-22 |
Poniard Pharmaceuticals, Inc. |
Oral formulations for picoplatin
|
|
US9193763B2
(en)
|
2007-08-17 |
2015-11-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
SI2644192T1
(sl)
|
2007-09-28 |
2017-08-31 |
Pfizer Inc. |
Ciljanje rakavih celic z uporabo nanodelcev
|
|
CA2917512C
(en)
|
2007-10-12 |
2025-08-05 |
President And Fellows Of Harvard College |
VACCINE NANOTECHNOLOGY
|
|
US9422234B2
(en)
*
|
2007-11-30 |
2016-08-23 |
The Johns Hopkins University |
Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancer
|
|
EP2249644A4
(en)
*
|
2008-02-08 |
2012-05-30 |
Poniard Pharmaceuticals Inc |
PICOPLATIN AND AMRUBICIN FOR THE TREATMENT OF LUNG CANCER
|
|
US8034396B2
(en)
*
|
2008-04-01 |
2011-10-11 |
Tyco Healthcare Group Lp |
Bioadhesive composition formed using click chemistry
|
|
ES2498091T3
(es)
*
|
2008-04-28 |
2014-09-24 |
Novartis Ag |
Procedimiento para producir nanopartículas
|
|
EA020954B1
(ru)
|
2008-06-16 |
2015-03-31 |
Бинд Терапьютикс, Инк. |
Загруженные лекарственным средством полимерные наночастицы, фармацевтическая композиция и способ лечения рака
|
|
EP2309991B1
(en)
*
|
2008-06-16 |
2019-03-06 |
Pfizer Inc |
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
|
|
WO2010005726A2
(en)
|
2008-06-16 |
2010-01-14 |
Bind Biosciences Inc. |
Therapeutic polymeric nanoparticles with mtor inhibitors and methods of making and using same
|
|
AU2009276423B2
(en)
|
2008-08-01 |
2014-10-30 |
The Johns Hopkins University |
PSMA-binding agents and uses thereof
|
|
WO2010027428A1
(en)
|
2008-08-26 |
2010-03-11 |
Massachusetts Institute Of Technology |
Platinum ( iv) complexes for use in dual mode pharmaceutical therapy
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8603532B2
(en)
|
2008-10-20 |
2013-12-10 |
Massachusetts Institute Of Technology |
Nanostructures for drug delivery
|
|
WO2010068866A2
(en)
*
|
2008-12-12 |
2010-06-17 |
Bind Biosciences |
Therapeutic particles suitable for parenteral administration and methods of making and using same
|
|
US8846096B2
(en)
*
|
2008-12-12 |
2014-09-30 |
Creighton University |
Nanoparticles and methods of use
|
|
EP2379064B1
(en)
*
|
2008-12-15 |
2020-02-26 |
Pfizer Inc. |
Long circulating nanoparticles for sustained release of therapeutic agents
|
|
EP2210584A1
(en)
*
|
2009-01-27 |
2010-07-28 |
Bayer Schering Pharma Aktiengesellschaft |
Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
|
|
AU2010215202A1
(en)
|
2009-02-21 |
2011-10-13 |
Covidien Lp |
Crosslinked fibers and method of making same using UV radiation
|
|
US9375699B2
(en)
|
2009-02-21 |
2016-06-28 |
Sofradim Production |
Apparatus and method of reacting polymers by exposure to UV radiation to produce injectable medical devices
|
|
US8968818B2
(en)
|
2009-02-21 |
2015-03-03 |
Covidien Lp |
Medical devices having activated surfaces
|
|
US9273191B2
(en)
|
2009-02-21 |
2016-03-01 |
Sofradim Production |
Medical devices with an activated coating
|
|
EP2398845B1
(en)
|
2009-02-21 |
2017-12-13 |
Sofradim Production |
Amphiphilic compounds and self-assembling compositions made therefrom
|
|
US8968733B2
(en)
*
|
2009-02-21 |
2015-03-03 |
Sofradim Production |
Functionalized surgical adhesives
|
|
WO2010096649A1
(en)
|
2009-02-21 |
2010-08-26 |
Tyco Healthcare Group Lp |
Medical devices having activated surfaces
|
|
AU2010215194A1
(en)
|
2009-02-21 |
2011-10-13 |
Sofradim Production |
Apparatus and method of reacting polymers passing through metal ion chelated resin matrix to produce injectable medical devices
|
|
EP2398941B1
(en)
|
2009-02-21 |
2016-07-13 |
Sofradim Production |
Crosslinked fibers and method of making same by extrusion
|
|
US8663689B2
(en)
*
|
2009-02-21 |
2014-03-04 |
Sofradim Production |
Functionalized adhesive medical gel
|
|
US8512728B2
(en)
|
2009-02-21 |
2013-08-20 |
Sofradim Production |
Method of forming a medical device on biological tissue
|
|
US8535477B2
(en)
|
2009-02-21 |
2013-09-17 |
Sofradim Production |
Medical devices incorporating functional adhesives
|
|
EP2398519A2
(en)
|
2009-02-21 |
2011-12-28 |
Sofradim Production |
Compounds and medical devices activated with solvophobic linkers
|
|
US8877170B2
(en)
*
|
2009-02-21 |
2014-11-04 |
Sofradim Production |
Medical device with inflammatory response-reducing coating
|
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
|
EA201171195A8
(ru)
*
|
2009-03-30 |
2014-08-29 |
Серулин Фарма Инк. |
Конъюгаты, частицы, композиции "полимер-агент" и способы их применения
|
|
WO2010114768A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-epothilone conjugates, particles, compositions, and related methods of use
|
|
CN101536982B
(zh)
*
|
2009-04-27 |
2011-11-09 |
中国人民解放军第二军医大学 |
Trastuzumab修饰的包裹毒素蛋白的PEG化免疫脂质体及其制备与应用
|
|
WO2011005363A2
(en)
*
|
2009-05-18 |
2011-01-13 |
Ensysce Biosciences, Inc. |
Carbon nanotubes complexed with multiple bioactive agents and methods related thereto
|
|
US9937128B2
(en)
|
2009-08-03 |
2018-04-10 |
The University Of North Carolina At Chapel Hill |
Liposomes comprising a calcium phosphate-containing precipitate
|
|
US12083191B2
(en)
|
2009-10-19 |
2024-09-10 |
Case Western Reserve University |
Composition and methods for imaging cells
|
|
WO2011063356A2
(en)
*
|
2009-11-22 |
2011-05-26 |
Sirnaomics, Inc. |
Rare earth-doped up-conversion nanoparticles for therapeutic and diagnostic applications
|
|
TR201906255T4
(tr)
|
2009-12-11 |
2019-05-21 |
Pfizer |
Terapötik partiküllerin liyofilize edilmesine yönelik stabil formülasyonlar.
|
|
ES2780156T3
(es)
|
2009-12-15 |
2020-08-24 |
Pfizer |
Composiciones terapéuticas de nanopartículas poliméricas con alta temperatura de transición vítrea o copolímeros de alto peso molecular
|
|
EA201290497A1
(ru)
*
|
2009-12-15 |
2013-01-30 |
Байнд Байосайенсиз, Инк. |
Терапевтические полимерные наночастицы, включающие кортикостероиды, и способы получения таковых
|
|
WO2011084521A2
(en)
*
|
2009-12-15 |
2011-07-14 |
Bind Biosciences, Inc. |
Therapeutic polymeric nanoparticles comprising epothilone and methods of making and using same
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
AU2011231246B2
(en)
|
2010-03-25 |
2015-05-21 |
Sofradim Production |
Surgical fasteners and methods for sealing wounds
|
|
EP2550031B1
(en)
|
2010-03-25 |
2015-08-19 |
Sofradim Production |
Medical devices incorporating functional adhesives
|
|
US9168225B2
(en)
|
2010-04-23 |
2015-10-27 |
The Board Of Trustees Of The University Of Illinois |
Nano-hybrid delivery system for sequential utilization of passive and active targeting
|
|
WO2011143524A2
(en)
|
2010-05-14 |
2011-11-17 |
Mallinckrodt Llc |
Functional, cross-linked nanostructures for tandem optical imaging and therapy
|
|
AU2011276443A1
(en)
|
2010-06-29 |
2013-01-31 |
Covidien Lp |
Microwave-powered reactor and method for in situ forming implants
|
|
WO2012001532A2
(en)
|
2010-07-01 |
2012-01-05 |
Sofradim Production |
Medical device with predefined activated cellular integration
|
|
AU2011284449B2
(en)
|
2010-07-27 |
2015-07-23 |
Sofradim Production |
Polymeric fibers having tissue reactive members
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
WO2012031205A2
(en)
*
|
2010-09-03 |
2012-03-08 |
The Brigham And Women's Hospital, Inc. |
Lipid-polymer hybrid particles
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
EP2629760A4
(en)
*
|
2010-10-22 |
2014-04-02 |
Bind Therapeutics Inc |
THERAPEUTIC NANOPARTICLES CONTAINING COPOLYMERS OF HIGH MOLECULAR WEIGHT
|
|
WO2012059936A1
(en)
|
2010-11-03 |
2012-05-10 |
Padma Venkitachalam Devarajan |
Pharmaceutical compositions for colloidal drug delivery
|
|
US10285943B2
(en)
|
2010-12-02 |
2019-05-14 |
Greenmark Biomedical Inc. |
Aptamer bioconjugate drug delivery device
|
|
US10363309B2
(en)
|
2011-02-04 |
2019-07-30 |
Case Western Reserve University |
Targeted nanoparticle conjugates
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
US20140308363A1
(en)
*
|
2011-05-31 |
2014-10-16 |
Bind Therapeutics, Inc. |
Drug loaded polymeric nanoparticles and methods of making and using same
|
|
EP2723324A1
(en)
|
2011-06-21 |
2014-04-30 |
Massachusetts Institute Of Technology |
Compositions and methods for the treatment of cancer
|
|
US9605304B2
(en)
*
|
2011-07-20 |
2017-03-28 |
The Hong Kong Polytechnic University |
Ultra-stable oligonucleotide-gold and-silver nanoparticle conjugates and method of their preparation
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2747761A1
(en)
*
|
2011-09-22 |
2014-07-02 |
Bind Therapeutics, Inc. |
Methods of treating cancers with therapeutic nanoparticles
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
WO2013059634A1
(en)
|
2011-10-20 |
2013-04-25 |
The Regents Of The University Of California |
Use of cdk9 inhibitors to reduce cartilage degradation
|
|
EP2592146A3
(en)
*
|
2011-11-14 |
2013-07-24 |
Silenseed Ltd |
Methods and compositions for treating prostate cancer
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
CN108949772A
(zh)
|
2012-04-02 |
2018-12-07 |
现代泰克斯公司 |
用于产生与人类疾病相关的生物制剂和蛋白质的修饰多核苷酸
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
WO2013151771A1
(en)
|
2012-04-05 |
2013-10-10 |
Massachusetts Institute Of Technology |
Immunostimulatory compositions and methods of use thereof
|
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
|
US8729286B2
(en)
|
2012-05-10 |
2014-05-20 |
Massachusetts Institute Of Technology |
Platinum compounds as treatment for cancers, and related methods, kits, and compositions
|
|
CA2790763A1
(en)
*
|
2012-05-31 |
2013-11-30 |
Ecosynthetix Ltd. |
Aptamer bioconjugate drug delivery device
|
|
CN103566377A
(zh)
|
2012-07-18 |
2014-02-12 |
上海博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
CN104736181A
(zh)
|
2012-08-10 |
2015-06-24 |
北德克萨斯大学健康科学中心 |
包含靶向聚氨基酸与脂肪酸之缀合物的药物递送载剂
|
|
JP2014051478A
(ja)
*
|
2012-09-10 |
2014-03-20 |
Panasonic Corp |
機能性物質、生体活性用薬剤及び機能性物質の生体内への浸透方法、並びに機能性物質放散装置及び空気清浄装置
|
|
EP2895156B1
(en)
|
2012-09-17 |
2019-05-08 |
Pfizer Inc. |
Process for preparing therapeutic nanoparticles
|
|
US9931410B2
(en)
*
|
2012-10-09 |
2018-04-03 |
The Brigham And Women's Hospital, Inc. |
Nanoparticles for targeted delivery of multiple therapeutic agents and methods of use
|
|
US9801953B2
(en)
|
2012-10-15 |
2017-10-31 |
Emory University |
Nanoparticles carrying nucleic acid cassettes for expressing RNA
|
|
EP2911701A4
(en)
*
|
2012-10-23 |
2016-06-08 |
Univ Johns Hopkins |
Novel self-assembling drug amphiphiles and methods for synthesis and application
|
|
AU2013344778C1
(en)
|
2012-11-15 |
2024-06-27 |
Endocyte, Inc. |
Conjugates for treating diseases caused by PSMA expressing cells
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
US20140187501A1
(en)
*
|
2012-12-28 |
2014-07-03 |
Blend Therapeutics, Inc. |
Targeted Conjugates Encapsulated in Particles and Formulations Thereof
|
|
WO2014121291A2
(en)
|
2013-02-04 |
2014-08-07 |
University Of Notre Dame Du Lac |
Nanoparticle drug delivery systems
|
|
EP2958596B1
(en)
|
2013-02-15 |
2019-12-04 |
Case Western Reserve University |
Psma ligands and uses thereof
|
|
US11975074B2
(en)
|
2013-02-15 |
2024-05-07 |
Case Western Reserve University |
Photodynamic therapy composition
|
|
US12465651B2
(en)
|
2013-02-15 |
2025-11-11 |
Case Western Reserve University |
Photodynamic therapy composition
|
|
US10207005B2
(en)
|
2013-02-15 |
2019-02-19 |
Case Western Reserve University |
Photodynamic therapy composition
|
|
WO2014131376A1
(en)
*
|
2013-02-26 |
2014-09-04 |
Elmarco S.R.O. |
Electrospun nanofibers comprising pharmaceutically active agents
|
|
US9133225B2
(en)
|
2013-03-13 |
2015-09-15 |
Massachusetts Institute Of Technology |
Dual targeting anticancer agents
|
|
SG10201707518YA
(en)
|
2013-03-14 |
2017-10-30 |
Regeneron Pharma |
Human antibodies to grem 1
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
KR102233251B1
(ko)
*
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
신규 나노입자 조성물
|
|
WO2014165782A2
(en)
|
2013-04-05 |
2014-10-09 |
Massachusetts Institute Of Technology |
Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety
|
|
EP3003403A4
(en)
*
|
2013-06-03 |
2017-02-22 |
University of Southern California |
Targeted crosslinked multilamellar liposomes
|
|
US9775928B2
(en)
|
2013-06-18 |
2017-10-03 |
Covidien Lp |
Adhesive barbed filament
|
|
US10434194B2
(en)
|
2013-06-20 |
2019-10-08 |
Case Western Reserve University |
PSMA targeted nanobubbles for diagnostic and therapeutic applications
|
|
US9657094B2
(en)
*
|
2013-06-24 |
2017-05-23 |
Colorado School Of Mines |
Biodegradable polymers for delivery of therapeutic agents
|
|
HUE056760T2
(hu)
|
2013-07-11 |
2022-03-28 |
Modernatx Inc |
A CRISPR-hez kapcsolódó fehérjéket és a szintetikus SGRNS-ket kódoló szintetikus polinukleotidokat tartalmazó készítmények és felhasználási módjaik
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
EP3456700A1
(en)
|
2013-10-18 |
2019-03-20 |
Deutsches Krebsforschungszentrum |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
US9504405B2
(en)
|
2013-10-23 |
2016-11-29 |
Verily Life Sciences Llc |
Spatial modulation of magnetic particles in vasculature by external magnetic field
|
|
US10542918B2
(en)
|
2013-10-23 |
2020-01-28 |
Verily Life Sciences Llc |
Modulation of a response signal to distinguish between analyte and background signals
|
|
US9975942B2
(en)
|
2013-11-11 |
2018-05-22 |
Wake Forest University Health Services |
EPHA3 And multi-valent targeting of tumors
|
|
CN105849568B
(zh)
*
|
2013-11-14 |
2018-05-04 |
恩多塞特公司 |
用于正电子发射断层术的化合物
|
|
CA3236835A1
(en)
|
2013-11-22 |
2015-05-28 |
Mina Therapeutics Limited |
C/ebp alpha short activating rna compositions and methods of use
|
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
|
EP3779446A1
(en)
|
2013-12-11 |
2021-02-17 |
University of Massachusetts |
Compositions and methods for treating disease using salmonella t3ss effector protein (sipa)
|
|
EP3082760A1
(en)
|
2013-12-19 |
2016-10-26 |
Novartis AG |
LEPTIN mRNA COMPOSITIONS AND FORMULATIONS
|
|
EP3092255A4
(en)
|
2014-01-10 |
2017-09-20 |
Birdie Biopharmaceuticals Inc. |
Compounds and compositions for treating egfr expressing tumors
|
|
AU2015213595A1
(en)
*
|
2014-02-10 |
2016-09-08 |
Salk Institute For Biological Studies |
Increasing storage of vitamin A, vitamin D and/or lipids
|
|
ES2834927T3
(es)
|
2014-03-14 |
2021-06-21 |
Pfizer |
Nanopartículas terapéuticas que comprenden un agente terapéutico y procedimientos de fabricación y uso de las mismas
|
|
CN103861112B
(zh)
*
|
2014-03-25 |
2015-12-30 |
国家纳米科学中心 |
基于聚合物纳米粒子载体的药物组合物及其制备方法
|
|
CN106661231A
(zh)
*
|
2014-04-24 |
2017-05-10 |
伦斯勒理工学院 |
无基质的聚合物纳米复合物及其相关产品和方法
|
|
SG10201911695SA
(en)
|
2014-05-14 |
2020-01-30 |
Targimmune Therapeutics Ag |
Improved polyethyleneimine polyethyleneglycol vectors
|
|
IL316479A
(en)
|
2014-06-25 |
2024-12-01 |
Acuitas Therapeutics Inc |
Novel lipids and lipid nanoparticle compositions for nucleic acid delivery
|
|
CA2954446A1
(en)
|
2014-07-09 |
2016-01-14 |
Shanghai Birdie Biotech, Inc. |
Anti-pd-l1 combinations for treating tumors
|
|
CN112546230A
(zh)
|
2014-07-09 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
|
EP3169693B1
(en)
|
2014-07-16 |
2022-03-09 |
ModernaTX, Inc. |
Chimeric polynucleotides
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
CN112546238A
(zh)
|
2014-09-01 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
|
CN104306332B
(zh)
*
|
2014-09-24 |
2017-02-15 |
东南大学 |
一种喜树碱类磷脂化合物、其药物组合物及应用
|
|
US9968688B2
(en)
|
2014-11-12 |
2018-05-15 |
Verily Life Sciences Llc |
Shielded targeting agents, methods, and in vivo diagnostic system
|
|
US11045428B2
(en)
|
2014-11-21 |
2021-06-29 |
University Of Maryland, Baltimore |
Decreased adhesivity receptor-targeted nanoparticles for Fn14-positive tumors
|
|
ES2832802T3
(es)
|
2014-11-21 |
2021-06-11 |
Univ Maryland |
Sistemas de administración dirigida del particulado específico de una estructura
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
US9861710B1
(en)
|
2015-01-16 |
2018-01-09 |
Verily Life Sciences Llc |
Composite particles, methods, and in vivo diagnostic system
|
|
EP3267975A4
(en)
|
2015-03-09 |
2018-08-08 |
The Regents of the University of California |
Polymer-drug conjugates for combination anticancer therapy
|
|
US10758520B1
(en)
|
2015-05-20 |
2020-09-01 |
University Of South Florida |
Glutathione-coated nanoparticles for delivery of MKT-077 across the blood-brain barrier
|
|
CN107613980A
(zh)
|
2015-05-31 |
2018-01-19 |
源生公司 |
用于免疫疗法的组合组合物
|
|
HUE067372T2
(hu)
|
2015-06-29 |
2024-10-28 |
Acuitas Therapeutics Inc |
Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
|
|
JP6938462B2
(ja)
|
2015-07-28 |
2021-09-22 |
ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System |
治療用化合物の脳への一方向送達のためのインプラント組成物
|
|
WO2017020026A1
(en)
|
2015-07-30 |
2017-02-02 |
Modernatx, Inc. |
Concatemeric peptide epitopes rnas
|
|
RS63030B1
(sr)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
|
|
WO2017053720A1
(en)
*
|
2015-09-25 |
2017-03-30 |
Tarveda Therapeutics, Inc. |
RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
|
|
SI3356385T1
(sl)
|
2015-09-30 |
2021-04-30 |
Deutsches Krebsforschungszentrum |
18F-označeni inhibitorji prostatnih membranskih antigenov (PSMA) in njihova uporaba kot slikovno prikazna sredstva za rak prostate
|
|
US20170128592A1
(en)
*
|
2015-10-01 |
2017-05-11 |
Indian Institute Of Technology, Bombay |
Targeted polymeric nano-complexes as drug delivery system
|
|
MD3718565T2
(ro)
|
2015-10-22 |
2022-09-30 |
Modernatx Inc |
Vaccinuri împotriva virusului respirator
|
|
EP3365009A4
(en)
|
2015-10-22 |
2019-07-03 |
ModernaTX, Inc. |
VACCINES AGAINST HERPES SIMPLEX VIRUS
|
|
EP3364981A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
|
|
AU2016342048B2
(en)
|
2015-10-22 |
2022-09-08 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
TN2018000154A1
(en)
|
2015-10-22 |
2019-10-04 |
Modernatx Inc |
Respiratory syncytial virus vaccine
|
|
CN108430456B
(zh)
|
2015-10-22 |
2022-01-18 |
摩登纳特斯有限公司 |
癌症疫苗
|
|
WO2017070601A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
RS63986B1
(sr)
|
2015-10-28 |
2023-03-31 |
Acuitas Therapeutics Inc |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
|
US20180271998A1
(en)
|
2015-12-04 |
2018-09-27 |
Merrimack Pharmaceuticals, Inc. |
Disulfide-stabilized fabs
|
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
|
WO2017112943A1
(en)
|
2015-12-23 |
2017-06-29 |
Modernatx, Inc. |
Methods of using ox40 ligand encoding polynucleotides
|
|
CN108713021A
(zh)
|
2015-12-30 |
2018-10-26 |
耶路撒冷希伯来大学伊森姆研究发展有限公司 |
Pt(IV)前药
|
|
CN115554406A
(zh)
|
2016-01-07 |
2023-01-03 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-cd20组合
|
|
CN115252792A
(zh)
|
2016-01-07 |
2022-11-01 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-egfr组合
|
|
CN106943598A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技（北京）有限公司 |
用于治疗肿瘤的抗-her2组合
|
|
WO2017120612A1
(en)
|
2016-01-10 |
2017-07-13 |
Modernatx, Inc. |
Therapeutic mrnas encoding anti ctla-4 antibodies
|
|
WO2017142876A1
(en)
|
2016-02-15 |
2017-08-24 |
University Of Georgia Research Foundation, Inc. |
lPA-3-LOADED LIPOSOMES AND METHODS OF USE THEREOF
|
|
WO2017147240A1
(en)
|
2016-02-23 |
2017-08-31 |
Tarveda Therapeutics, Inc. |
Hsp90 targeted conjugates and particles and formulations thereof
|
|
EP3439640B1
(en)
|
2016-04-08 |
2024-01-17 |
The Cleveland Clinic Foundation |
Nanoparticles for drug delivery to treat bone disease
|
|
WO2017192863A1
(en)
|
2016-05-04 |
2017-11-09 |
L.E.A.F. Holdings Group Llc |
Targeted liposomal gemcitabine compositions and methods thereof
|
|
JP6757061B2
(ja)
*
|
2016-05-09 |
2020-09-16 |
東京都公立大学法人 |
ドラッグデリバリー用脂質単層被覆型ナノ粒子
|
|
US10300145B2
(en)
|
2016-07-15 |
2019-05-28 |
Massachusetts Institute Of Technology |
Synthetic nanoparticles for delivery of immunomodulatory compounds
|
|
CN106176595B
(zh)
*
|
2016-08-31 |
2019-10-22 |
辰欣药业股份有限公司 |
一种更昔洛韦注射液及其制备工艺
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
TWI781130B
(zh)
|
2017-01-03 |
2022-10-21 |
美商再生元醫藥公司 |
抗金黃色葡萄球菌溶血素ａ毒素之人類抗體
|
|
ES3020935T3
(en)
|
2017-03-15 |
2025-05-23 |
Modernatx Inc |
Lipid nanoparticle formulation
|
|
CA3056133A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
KR20190132405A
(ko)
|
2017-03-15 |
2019-11-27 |
모더나티엑스, 인크. |
치료제의 세포내 전달을 위한 화합물 및 조성물
|
|
WO2018175273A1
(en)
*
|
2017-03-21 |
2018-09-27 |
The Regents Of The University Of Michigan |
Erg targeted therapy
|
|
US10369230B2
(en)
|
2017-04-06 |
2019-08-06 |
National Guard Health Affairs |
Sustained release of a therapeutic agent from PLA-PEG-PLA nanoparticles for cancer therapy
|
|
CN118515666A
(zh)
|
2017-04-27 |
2024-08-20 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
|
ES2981244T3
(es)
|
2017-04-28 |
2024-10-07 |
Acuitas Therapeutics Inc |
Novedosas formulaciones de nanopartículas de lípidos de carbonilo y lípidos para la administración de ácidos nucleicos
|
|
ES2952779T3
(es)
|
2017-05-18 |
2023-11-06 |
Modernatx Inc |
ARN mensajero modificado que comprende elementos de ARN funcionales
|
|
US11421011B2
(en)
|
2017-05-18 |
2022-08-23 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
|
NZ759175A
(en)
*
|
2017-06-22 |
2022-07-01 |
Snbioscience Inc |
Particle and pharmaceutical composition comprising an insoluble camptothecin compound with double core-shell structure and method for manufacturing the same
|
|
KR20200019226A
(ko)
|
2017-06-23 |
2020-02-21 |
버디 바이오파마슈티칼즈, 인크. |
약학 조성물
|
|
ES3015765T3
(en)
|
2017-07-17 |
2025-05-07 |
Medincell S A |
Pharmaceutical composition
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
CA3075205A1
(en)
|
2017-09-08 |
2019-03-14 |
Mina Therapeutics Limited |
Stabilized hnf4a sarna compositions and methods of use
|
|
EP4219715A3
(en)
|
2017-09-08 |
2023-09-06 |
MiNA Therapeutics Limited |
Stabilized cebpa sarna compositions and methods of use
|
|
EP3470056B1
(en)
*
|
2017-10-16 |
2022-04-27 |
Medtronic Vascular Inc. |
Therapeutic nanoparticles for treating vascular diseases
|
|
RU2669937C1
(ru)
*
|
2017-10-17 |
2018-10-17 |
федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) |
Фармацевтическая противоопухолевая композиция паклитаксела с гистоном Н1.3 в качестве носителя и способ получения композиции
|
|
JP7424976B2
(ja)
|
2017-11-22 |
2024-01-30 |
モダーナティエックス・インコーポレイテッド |
プロピオン酸血症の治療用のプロピオニルＣｏＡカルボキシラーゼアルファ及びベータサブユニットをコードするポリヌクレオチド
|
|
EP3714048B1
(en)
|
2017-11-22 |
2025-04-09 |
ModernaTX, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
WO2019104160A2
(en)
|
2017-11-22 |
2019-05-31 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
EP3735270A1
(en)
|
2018-01-05 |
2020-11-11 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
|
JP2021515797A
(ja)
*
|
2018-03-15 |
2021-06-24 |
アトッサ・セラピューティクス・インコーポレイテッド |
免疫反応誘導のインサイツ方法
|
|
WO2019183633A1
(en)
|
2018-03-23 |
2019-09-26 |
Case Western Reserve Univeristy |
Psma targeted conjugate compounds and uses thereof
|
|
US11666515B2
(en)
|
2018-03-28 |
2023-06-06 |
Greenmark Biomedical Inc. |
Phosphate crosslinked starch nanoparticle and dental treatments
|
|
EP3773742A4
(en)
*
|
2018-04-06 |
2022-03-16 |
North Carolina State University |
CELL SET-MEDIATED CHECKPOINT INHIBITOR DELIVERY FOR CANCER IMMUNOTHERAPY
|
|
EP3773745A1
(en)
|
2018-04-11 |
2021-02-17 |
ModernaTX, Inc. |
Messenger rna comprising functional rna elements
|
|
EP4242307A3
(en)
|
2018-04-12 |
2023-12-27 |
MiNA Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
KR20210003135A
(ko)
|
2018-04-17 |
2021-01-11 |
엔도사이트, 인코포레이티드 |
암의 치료 방법
|
|
US20220175750A1
(en)
*
|
2018-04-23 |
2022-06-09 |
The Regents Of The University Of California |
Sustained release formulation for local delivery of cdk9 inhibitors
|
|
CA3098873A1
(en)
|
2018-05-11 |
2019-11-14 |
Phosphorex, Inc. |
Microparticles and nanoparticles having negative surface charges
|
|
US20210346306A1
(en)
|
2018-05-23 |
2021-11-11 |
Modernatx, Inc. |
Delivery of dna
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
US20210317461A1
(en)
|
2018-08-09 |
2021-10-14 |
Verseau Therapeutics, Inc. |
Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof
|
|
EA201800477A1
(ru)
*
|
2018-08-28 |
2020-02-28 |
Ооо "Нпк Альфа-Онкотехнологии" |
Препарат для лечения онкологических заболеваний
|
|
WO2020047201A1
(en)
|
2018-09-02 |
2020-03-05 |
Modernatx, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
EP3849595B1
(en)
|
2018-09-13 |
2025-11-19 |
ModernaTX, Inc. |
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease
|
|
WO2020056155A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
US20220401584A1
(en)
|
2018-09-14 |
2022-12-22 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
IL281615B2
(en)
|
2018-09-21 |
2026-01-01 |
Acuitas Therapeutics Inc |
Systems and methods for producing lipid nanoparticles and liposomes
|
|
EP3856233A1
(en)
|
2018-09-27 |
2021-08-04 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
US12583816B2
(en)
|
2018-10-18 |
2026-03-24 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
WO2020097409A2
(en)
|
2018-11-08 |
2020-05-14 |
Modernatx, Inc. |
Use of mrna encoding ox40l to treat cancer in human patients
|
|
JP2022517554A
(ja)
*
|
2018-12-31 |
2022-03-09 |
サン－ゴバン パフォーマンス プラスティックス コーポレイション |
分解性担体を収容する容器
|
|
JP7523449B2
(ja)
|
2019-01-11 |
2024-07-26 |
アクイタス セラピューティクス インコーポレイテッド |
活性剤の脂質ナノ粒子送達のための脂質
|
|
WO2020150740A1
(en)
*
|
2019-01-18 |
2020-07-23 |
Case Western Reserve University |
Psma ligand targeted compounds and uses thereof
|
|
EP3941511A2
(en)
|
2019-03-20 |
2022-01-26 |
Massachusetts Institute of Technology |
Uses of amphiphiles in immune cell therapy and compositions therefor
|
|
WO2020208361A1
(en)
|
2019-04-12 |
2020-10-15 |
Mina Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
CN114375190A
(zh)
|
2019-05-08 |
2022-04-19 |
阿斯利康(瑞典)有限公司 |
用于皮肤和伤口的组合物及其使用方法
|
|
JP7604397B2
(ja)
|
2019-05-20 |
2024-12-23 |
エンドサイト・インコーポレイテッド |
Ｐｓｍａコンジュゲートの調製方法
|
|
MA56203A
(fr)
|
2019-06-12 |
2022-04-20 |
Regeneron Pharma |
Anticorps humains dirigés contre la protéine morphogénétique osseuse 6
|
|
CN114258398A
(zh)
|
2019-06-13 |
2022-03-29 |
总医院公司 |
工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
|
|
US20220387628A1
(en)
|
2019-06-24 |
2022-12-08 |
Modernatx, Inc. |
Messenger rna comprising functional rna elements and uses thereof
|
|
WO2020263883A1
(en)
|
2019-06-24 |
2020-12-30 |
Modernatx, Inc. |
Endonuclease-resistant messenger rna and uses thereof
|
|
WO2021030160A1
(en)
|
2019-08-09 |
2021-02-18 |
Bio-Rad Laboratories, Inc. |
Polymer dots
|
|
MX2022003269A
(es)
|
2019-09-19 |
2022-07-04 |
Modernatx Inc |
Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos.
|
|
CA3155015A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
CN114391040A
(zh)
|
2019-09-23 |
2022-04-22 |
欧米茄治疗公司 |
用于调节载脂蛋白b(apob)基因表达的组合物和方法
|
|
AU2020352552A1
(en)
|
2019-09-23 |
2022-03-17 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expression
|
|
CA3163503A1
(en)
*
|
2019-12-03 |
2021-06-10 |
Onselex Pharmaceuticals, Inc. |
Polyphosphazene drug carriers
|
|
US12421558B2
(en)
|
2020-02-13 |
2025-09-23 |
10X Genomics, Inc. |
Systems and methods for joint interactive visualization of gene expression and DNA chromatin accessibility
|
|
WO2021183318A2
(en)
*
|
2020-03-09 |
2021-09-16 |
President And Fellows Of Harvard College |
Methods and compositions relating to improved combination therapies
|
|
WO2021183720A1
(en)
|
2020-03-11 |
2021-09-16 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
|
CA3184474A1
(en)
|
2020-06-01 |
2021-12-09 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
CA3181680A1
(en)
|
2020-06-12 |
2021-12-16 |
University Of Rochester |
Encoding and expression of ace-trnas
|
|
US12521435B2
(en)
|
2020-07-03 |
2026-01-13 |
Case Western Reserve University |
Photodynamic therapy composition
|
|
JP7798855B2
(ja)
|
2020-07-16 |
2026-01-14 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子に使用するためのカチオン性脂質
|
|
CN116670154A
(zh)
|
2020-07-24 |
2023-08-29 |
总医院公司 |
增强的病毒样颗粒及使用其递送至细胞的方法
|
|
JP2023544201A
(ja)
|
2020-10-08 |
2023-10-20 |
ターグイミューン セラピューティクス アクチエンゲゼルシャフト |
がんを処置するための免疫療法
|
|
WO2022104131A1
(en)
|
2020-11-13 |
2022-05-19 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
GB2603454A
(en)
|
2020-12-09 |
2022-08-10 |
Ucl Business Ltd |
Novel therapeutics for the treatment of neurodegenerative disorders
|
|
CN117479963A
(zh)
*
|
2020-12-18 |
2024-01-30 |
盖纳万科学有限公司 |
Peg脂质和脂质纳米粒子
|
|
US12194058B2
(en)
|
2021-01-06 |
2025-01-14 |
Florida Atlantic University Board Of Trustees |
Cancer treatment regimen using anti-parasitic compounds and gut microbiome modulating agents
|
|
JP2024505195A
(ja)
|
2021-01-25 |
2024-02-05 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗ｐｄｇｆ－ｂ抗体及び肺動脈高血圧症（ｐａｈ）を治療するための使用方法
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
WO2022204370A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
WO2022204371A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
US20240226025A1
(en)
|
2021-03-24 |
2024-07-11 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
CA3214137A1
(en)
|
2021-03-26 |
2022-09-29 |
Mina Therapeutics Limited |
Tmem173 sarna compositions and methods of use
|
|
EP4337177A1
(en)
|
2021-05-11 |
2024-03-20 |
Modernatx, Inc. |
Non-viral delivery of dna for prolonged polypeptide expression in vivo
|
|
US20240384277A1
(en)
|
2021-06-15 |
2024-11-21 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
US20240376445A1
(en)
|
2021-06-22 |
2024-11-14 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
WO2023283359A2
(en)
|
2021-07-07 |
2023-01-12 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
|
WO2023056044A1
(en)
|
2021-10-01 |
2023-04-06 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023059809A2
(en)
*
|
2021-10-06 |
2023-04-13 |
The Regents Of The University Of California |
Methods and agents for prevention of viral proliferation
|
|
WO2023079142A2
(en)
|
2021-11-05 |
2023-05-11 |
Targimmune Therapeutics Ag |
Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
|
CA3237590A1
(en)
|
2021-11-09 |
2023-05-08 |
James Basilion |
Psma targeted conjugate compounds and uses thereof
|
|
WO2023099884A1
(en)
|
2021-12-01 |
2023-06-08 |
Mina Therapeutics Limited |
Pax6 sarna compositions and methods of use
|
|
GB202117758D0
(en)
|
2021-12-09 |
2022-01-26 |
Ucl Business Ltd |
Therapeutics for the treatment of neurodegenerative disorders
|
|
CA3242402A1
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
US20250134919A1
(en)
|
2022-02-07 |
2025-05-01 |
University Of Rochester |
OPTIMIZED SEQUENCES FOR ENHANCED tRNA EXPRESSION OR/AND NONSENSE MUTATION SUPPRESSION
|
|
WO2023161350A1
(en)
|
2022-02-24 |
2023-08-31 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
WO2023170435A1
(en)
|
2022-03-07 |
2023-09-14 |
Mina Therapeutics Limited |
Il10 sarna compositions and methods of use
|
|
WO2023177904A1
(en)
|
2022-03-18 |
2023-09-21 |
Modernatx, Inc. |
Sterile filtration of lipid nanoparticles and filtration analysis thereof for biological applications
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
WO2023196399A1
(en)
|
2022-04-06 |
2023-10-12 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding argininosuccinate lyase for the treatment of argininosuccinic aciduria
|
|
WO2023215498A2
(en)
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
|
MA71619A
(fr)
|
2022-07-26 |
2025-05-30 |
Modernatx, Inc. |
Polynucléotides modifiés pour la régulation temporelle de l'expression
|
|
WO2024044147A1
(en)
|
2022-08-23 |
2024-02-29 |
Modernatx, Inc. |
Methods for purification of ionizable lipids
|
|
WO2024097639A1
(en)
|
2022-10-31 |
2024-05-10 |
Modernatx, Inc. |
Hsa-binding antibodies and binding proteins and uses thereof
|
|
AU2023376546A1
(en)
|
2022-11-07 |
2025-05-15 |
Targimmune Therapeutics Ag |
Targeted linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
|
JP2025537216A
(ja)
|
2022-11-07 |
2025-11-14 |
ターグイミューン セラピューティクス アクチエンゲゼルシャフト |
核酸とポリエチレンイミンおよびポリエチレングリコールを含む標的化コンジュゲートとのポリプレックス
|
|
EP4615509A1
(en)
|
2022-11-07 |
2025-09-17 |
TargImmune Therapeutics AG |
Psma-targeting linear conjugates comprising polyethyleneimine and polyethylene glycol and polyplexes comprising the same
|
|
CN115844822B
(zh)
*
|
2022-11-23 |
2024-05-14 |
上海交通大学医学院附属第九人民医院 |
一种口服载药胶束组合物及其制备方法
|
|
WO2024118866A1
(en)
|
2022-12-01 |
2024-06-06 |
Modernatx, Inc. |
Gpc3-specific antibodies, binding domains, and related proteins and uses thereof
|
|
WO2024125597A1
(en)
|
2022-12-14 |
2024-06-20 |
Providence Therapeutics Holdings Inc. |
Compositions and methods for infectious diseases
|
|
WO2024130158A1
(en)
|
2022-12-16 |
2024-06-20 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding extended serum half-life interleukin-22 for the treatment of metabolic disease
|
|
WO2024134199A1
(en)
|
2022-12-22 |
2024-06-27 |
Mina Therapeutics Limited |
Chemically modified sarna compositions and methods of use
|
|
KR20250155004A
(ko)
|
2023-02-23 |
2025-10-29 |
유니버시티 오브 로체스터 |
폐쇄 말단 dna 가닥 분자를 제조하기 위한 제제 및 방법
|
|
WO2024182301A2
(en)
|
2023-02-27 |
2024-09-06 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding galactose-1-phosphate uridylyltransferase (galt) for the treatment of galactosemia
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
WO2024206126A1
(en)
|
2023-03-27 |
2024-10-03 |
Modernatx, Inc. |
Cd16-binding antibodies and uses thereof
|
|
WO2024206329A1
(en)
|
2023-03-27 |
2024-10-03 |
Modernatx, Inc. |
Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof
|
|
AU2024265267A1
(en)
|
2023-05-03 |
2025-11-20 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2024243438A2
(en)
|
2023-05-23 |
2024-11-28 |
Omega Therapeutics, Inc. |
Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
|
|
WO2025042806A2
(en)
|
2023-08-21 |
2025-02-27 |
Modernatx, Inc. |
C-met binding antibodies, nucleic acids encoding same, and methods of use
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
CN117683372A
(zh)
*
|
2023-10-14 |
2024-03-12 |
江苏荣耀光学科技有限公司 |
一种纳米光热试剂及其制备方法与应用
|
|
WO2025101685A1
(en)
|
2023-11-09 |
2025-05-15 |
University Of Rochester |
Suppression of nonsense mutations using anticodon engineered (ace)-trnas
|
|
WO2025238236A1
(en)
|
2024-05-16 |
2025-11-20 |
Targimmune Therapeutics Ag |
Polyplexes of nucleic acids and targeted conjugates comprising polyethyleneimine and polyethylene glycol
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|
|
WO2026006151A2
(en)
|
2024-06-24 |
2026-01-02 |
University Of Rochester |
Functionalization of ace-trna encoding synthetic linear picovectors
|
|
WO2026030209A1
(en)
|
2024-07-29 |
2026-02-05 |
University Of Rochester |
Use of decoding trnas to boost protein expression or function
|
|
WO2026027887A2
(en)
|
2024-08-02 |
2026-02-05 |
Mina Therapeutics Limited |
Hbg1/2-sarna compositions and methods of use
|
|
WO2026044055A1
(en)
|
2024-08-23 |
2026-02-26 |
Modernatx, Inc. |
Muc16 binding molecules, nucleic acids encoding same, and methods of use
|
|
WO2026075820A1
(en)
|
2024-10-03 |
2026-04-09 |
Modernatx, Inc. |
4-1bb binding molecules, nucleic acids encoding same, and methods of use
|